Liquidia Corp (LQDA)
10.65
+0.50
(+4.93%)
USD |
NASDAQ |
Nov 22, 16:00
10.64
0.00 (0.00%)
After-Hours: 20:00
Liquidia Price to Book Value: 8.156 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
November 22, 2024 | 8.156 |
November 21, 2024 | 7.773 |
November 20, 2024 | 7.750 |
November 19, 2024 | 7.781 |
November 18, 2024 | 7.520 |
November 15, 2024 | 7.536 |
November 14, 2024 | 7.677 |
November 13, 2024 | 7.865 |
November 12, 2024 | 8.141 |
November 11, 2024 | 8.217 |
November 08, 2024 | 8.447 |
November 07, 2024 | 8.294 |
November 06, 2024 | 8.148 |
November 05, 2024 | 7.988 |
November 04, 2024 | 8.010 |
November 01, 2024 | 8.409 |
October 31, 2024 | 8.309 |
October 30, 2024 | 8.432 |
October 29, 2024 | 8.446 |
October 28, 2024 | 8.438 |
October 25, 2024 | 8.423 |
October 24, 2024 | 8.453 |
October 23, 2024 | 8.476 |
October 22, 2024 | 8.568 |
October 21, 2024 | 8.484 |
Date | Value |
---|---|
October 18, 2024 | 8.522 |
October 17, 2024 | 8.767 |
October 16, 2024 | 8.897 |
October 15, 2024 | 8.706 |
October 14, 2024 | 8.518 |
October 11, 2024 | 8.480 |
October 10, 2024 | 8.446 |
October 09, 2024 | 8.491 |
October 08, 2024 | 8.430 |
October 07, 2024 | 8.530 |
October 04, 2024 | 7.673 |
October 03, 2024 | 7.719 |
October 02, 2024 | 7.654 |
October 01, 2024 | 7.818 |
September 30, 2024 | 7.650 |
September 27, 2024 | 13.47 |
September 26, 2024 | 13.64 |
September 25, 2024 | 13.87 |
September 24, 2024 | 13.61 |
September 23, 2024 | 13.36 |
September 20, 2024 | 13.39 |
September 19, 2024 | 13.82 |
September 18, 2024 | 13.33 |
September 17, 2024 | 13.16 |
September 16, 2024 | 13.45 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.475
Minimum
Mar 29 2021
33.54
Maximum
Jul 06 2020
7.488
Average
5.190
Median
Price to Book Value Benchmarks
United Therapeutics Corp | 2.729 |
Paragon 28 Inc | 6.028 |
AIM ImmunoTech Inc | 4.596 |
Protalix BioTherapeutics Inc | 3.836 |
Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
PS Ratio | 50.46 |
PEG Ratio | -0.0748 |
Price | 10.65 |
Earnings Yield | -15.31% |
Market Cap | 901.38M |
PEGY Ratio | -0.0748 |